In the prospective arm, irrespective of eventual TB treatment, the prevalence of AlereLAM positivity in those with CD4 ≤ 100 cells/μL and not meeting ‘seriously ill’ criteria was 10.5% (n = 2/19) (Figure 3). Here, CD4 is linked to tuberculosis.